Chemical stock engaged in the manufacturing and supplying of Chlor Alkali & its Derivatives, agrohemicals and other products jumped 3 percent in the day’s trade following commissioning of additional capacity for CPVC plant and venturing into the production of CPVC compound.
With a market capitalization of Rs. 5,660 Crores, the shares of Epigral Limited were trading at Rs. 1,362.40, up 2.97 percent from its previous day’s close price of Rs. 1,323.05.
Epigral Limited has announced successful commissioning of an additional 45,000 Tonnes Per Annum (TPA) capacity of CPVC (Chlorinated Polyvinyl Chloride) resin plant at its Dahej facility in Gujarat.
With this expansion, Epigral Limited’s total CPVC resin capacity reaches 75,000 TPA positioning it as the largest CPVC resin facility in the world at a single location.The new capacity addition will help in reducing India’s reliance on imports of CPVC and further strengthen the country’s foreign exchange reserves
In addition to the CPVC resin capacity expansion, it is also venturing into CPVC compound production, with a projected capacity of 35,000 TPA. The project is under progress and is expected to be commissioned in the first quarter of the financial year 2025.
CPVC resin and CPVC compound are integral components in the manufacturing of CPVC pipes and fittings, renowned for their high heat and chemical resistance properties, thus making them suitable for both domestic and industrial applications
Epigral Limitd is primarily engaged in the manufacturing and supplying of Chlor Alkali & its Derivatives, agrohemicals and other products like chlorinated polyvinyl chloride (CPVC) resin, caustic soda, caustic potash, chlorine, hydrogen, hydrogen peroxide and many more.
Its revenue from operations declined by 12.26 percent from Rs. 538 Crores in Q3FY23 to Rs. 472 Crores in Q3FY24, accompanied by profits of Rs. 77 Crores to Rs. 49 Crores.
It has reported a return on equity (ROE) of 39.4 percent and a return on capital employed (ROCE) of 32.1 percent, it is making good returns on its equity and capital employed.
Written by: Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
